Philippe Collery

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 2

Top Topics

Candida Albicans

Transforming Growth Factor

Breast Cancer Risk

Top Venues

Current pharmaceutical design

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Philippe Collery, Didier Desmaële, Adhikesavan Harikrishnan, Vijay Veena
Remarkable Effects of a Rhenium(I)-diselenoether Drug on the Production of Cathepsins B and S by Macrophages and Their Polarizations. Current pharmaceutical design (2023)
Philippe Collery, Vijay Veena, Adhikesavan Harikrishnan, Didier Desmaele
The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers. Investigational new drugs 37 (5) (2019)